The first meeting (15 February 2015) focused on 'health security' as an important theme under global health law, and in this context discussed the challenges posed by the recent Ebola crisis.
The second meeting will take place on 11 March 2016 in London. An important topic for that meeting will be the High-Level Panel on Access to Medicines that takes place prior to this meeting in London:
The United Nations Secretary-General has established a High-Level Panel on Access to Medicines . The High-Level Panel has made a call for proposals that address the misalignment between the rights of inventors, international human rights law, trade rules and public health where it impedes the innovation of and access to health technologies. In particular the High-Level Panel will consider contributions that promote research, development, innovation and increase access to medicines, vaccines, diagnostics and related health technologies to improve the health and wellbeing of all, as envisaged by Sustainable Development Goal 3, and the 2030 Agenda for Sustainable Development more broadly.
The Global Health Committee of the International Law Association has made two submissions to the UNHLP.
- Submission 1 contains proposals to establish an Essential Medicines Patent Pool, to implement effectively automatic compulsory licensing for essential medicines and authorize exemption of essential medicines from patenting.
- Submission 2 contains a proposal for a Framework Convention on Pharmaceutical Innovation with optional protocols touching upon intellectual property management, funding for innovation, administrative and regulatory tools relating to pharmaceutical approval processes, and international cooperation in science and technology.
|Last modified:||16 April 2019 09.50 a.m.|